Origin Life Sciences, Inc. (OLSI)

Origin Life Sciences will go public soon, but the exact IPO date is still unknown.

IPO Price

$4.00

Shares Offered

1,875,000

Deal Size

$7.50M

Origin Life Sciences Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2022	FY 2021
Period Ending	Dec '22 Dec 31, 2022	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Income	-3.02	-3.02	-6.48
Net Income	-8.84	-8.84	-6.33

Fiscal Year	Current	FY 2022	FY 2021
Period Ending	Dec '22 Dec 31, 2022	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	0.55	0.55	0
Total Debt	2.68	2.68	1.31
Net Cash (Debt)	-2.13	-2.13	-1.3
Net Cash Growth	-	-	-

Fiscal Year	TTM	FY 2022	FY 2021
Period Ending	Dec '22 Dec 31, 2022	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-1.36	-1.36	-0.92
Free Cash Flow	-1.36	-1.36	-0.92
Free Cash Flow Growth	-	-	-